Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects

V. W. Henderson, A. Paganini-Hill, C. K. Emanuel, M. E. Dunn and J. G. Buckwalter
Department of Neurology (Division of Cognitive Neuroscience and Neurogerontology), University of Southern California, Los Angeles.

OBJECTIVES: We hypothesized that oral estrogen replacement therapy would be less common among elderly women meeting criteria for Alzheimer's disease (AD) than among nondemented elderly women. For women with AD, we hypothesized that estrogen users would perform better on a cognitive task than would nonusers. DESIGN: A case-control study of estrogen replacement therapy, in which hierarchical procedures were used to control for potentially confounding effects of age and education. When cognitive performances were compared between estrogen users and nonusers with AD, the duration of dementia symptoms was an additional control variable. SETTING: Alzheimer's Disease Research Center at the University of Southern California, Los Angeles. SUBJECTS: Subjects were a volunteer sample of consecutively enrolled elderly women, recruited primarily from the community, who met clinical criteria for probable AD (n = 143) or met criteria for nondemented control status (n = 92). Seventy case patients who have subsequently died met histopathologic criteria for AD; one other demented woman who did not meet the autopsy criteria for AD was excluded from all analyses. MAIN OUTCOME MEASURES: Current use of estrogen replacement at the time of enrollment as reported by control subjects or by the primary caregivers of AD case patients. Among cases, performances on a brief cognitive screening instrument were compared between estrogen users (n = 10) and nonusers (n = 128) for whom this information was available. RESULTS: Alzheimer's disease case patients were significantly less likely than control subjects to use estrogen replacement (7% vs 18%), but groups did not differ with regard to the total number of prescription medications or to the most frequently prescribed class of drug (thyroid medication). Demented case patients using estrogen did not differ significantly from those not using estrogen in terms of age, education, or symptom duration, but their mean performance on a cognitive screening instrument was significantly better (Mini-Mental State examination scores of 14.9 vs 6.5). CONCLUSIONS: Findings are consistent with contentions that postmenopausal estrogen replacement therapy may be associated with a decreased risk of AD and that estrogen replacement may improve cognitive performance of women with this illness.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Incidence of Dementia in Long-term Hormone Users
Petitti et al.
Am J Epidemiol 2008;167:692-700.
ABSTRACT | FULL TEXT  

Behavior-Based Interventions to Enhance Cognitive Functioning and Independence in Older Adults
Shumaker et al.
JAMA 2006;296:2852-2854.
FULL TEXT  

Neuroprotective Effects of 17beta-Estradiol and Nonfeminizing Estrogens against H2O2 Toxicity in Human Neuroblastoma SK-N-SH Cells
Wang et al.
Mol. Pharmacol. 2006;70:395-404.
ABSTRACT | FULL TEXT  

Novel Mechanisms for Estrogen-Induced Neuroprotection.
Singh et al.
Exp. Biol. Med. 2006;231:514-521.
ABSTRACT | FULL TEXT  

Familial Alzheimer disease in Latinos: Interaction between APOE, stroke, and estrogen replacement
Rippon et al.
Neurology 2006;66:35-40.
ABSTRACT | FULL TEXT  

Sex, Hormones, and Alzheimer's Disease
Baum
J. Gerontol. A Biol. Sci. Med. Sci. 2005;60:736-743.
ABSTRACT | FULL TEXT  

Effect of Raloxifene on Prevention of Dementia and Cognitive Impairment in Older Women: The Multiple Outcomes of Raloxifene Evaluation (MORE) Randomized Trial
Yaffe et al.
Am. J. Psychiatry 2005;162:683-690.
ABSTRACT | FULL TEXT  

Cognition and Dementia
Obstet Gynecol 2004;104:25S-40S.
FULL TEXT  

Conjugated Equine Estrogens and Incidence of Probable Dementia and Mild Cognitive Impairment in Postmenopausal Women: Women's Health Initiative Memory Study
Shumaker et al.
JAMA 2004;291:2947-2958.
ABSTRACT | FULL TEXT  

Estrogen and Dementia: Insights From the Women's Health Initiative Memory Study
Schneider
JAMA 2004;291:3005-3007.
FULL TEXT  

Sex Matters in Autism and Other Developmental Disabilities
Thompson et al.
J Intellect Disabil 2003;7:345-362.
ABSTRACT  

Oestrogen, brain function, and neuropsychiatric disorders
Cutter et al.
J. Neurol. Neurosurg. Psychiatry 2003;74:837-840.
FULL TEXT  

People with Dementia in a Rural Community: Issues of Prevalence and Community Care Policy
Gilmour et al.
Dementia 2003;2:245-263.
ABSTRACT  

Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women: The Women's Health Initiative Memory Study: A Randomized Controlled Trial
Shumaker et al.
JAMA 2003;289:2651-2662.
ABSTRACT | FULL TEXT  

Nulliparity and Late Menopause Are Associated With Decreased Cognitive Decline
McLay et al.
J. Neuropsychiatry Clin. Neurosi. 2003;15:161-167.
ABSTRACT | FULL TEXT  

Estrogen and Cognitive Functioning in Women
Sherwin
Endocr. Rev. 2003;24:133-151.
ABSTRACT | FULL TEXT  

Alzheimer Disease: Current Concepts and Emerging Diagnostic and Therapeutic Strategies
Clark and Karlawish
ANN INTERN MED 2003;138:400-410.
ABSTRACT | FULL TEXT  

Higher Estrogen Levels Are Not Associated With Larger Hippocampi and Better Memory Performance
den Heijer et al.
Arch Neurol 2003;60:213-220.
ABSTRACT | FULL TEXT  

Pharmacologic Agents Associated with a Preventive Effect on Alzheimer's Disease: A Review of the Epidemiologic Evidence
in 't Veld et al.
Epidemiol Rev 2002;24:248-268.
FULL TEXT  

Hormone Replacement Therapy and Incidence of Alzheimer Disease in Older Women: The Cache County Study
Zandi et al.
JAMA 2002;288:2123-2129.
ABSTRACT | FULL TEXT  

The Role of Hormone Replacement Therapy in the Prevention of Alzheimer Disease
Fillit
Arch Intern Med 2002;162:1934-1942.
ABSTRACT | FULL TEXT  

Amyloid Precursor Protein, Presenilins, and alpha -Synuclein: Molecular Pathogenesis and Pharmacological Applications in Alzheimer's Disease
Suh and Checler
Pharmacol. Rev. 2002;54:469-525.
ABSTRACT | FULL TEXT  

Postmenopausal Hormone Replacement Therapy: Scientific Review
Nelson et al.
JAMA 2002;288:872-881.
ABSTRACT | FULL TEXT  

Prevalence of Dementia in Users of Hormone Replacement Therapy as Defined by Prescription Data
Petitti et al.
J. Gerontol. A Biol. Sci. Med. Sci. 2002;57:M532-538.
ABSTRACT | FULL TEXT  

Relationship of Endogenous Levels of Sex Hormones to Cognition and Depression in Frail, Elderly Women
Breuer et al.
AJGP 2002;10:311-320.
ABSTRACT | FULL TEXT  

Genetic and host factors for dementia in Down's syndrome
SCHUPF and Sergievsky
Br. J. Psychiatry 2002;180:405-410.
ABSTRACT | FULL TEXT  

APOE genotype and survival in men and women with Alzheimer's disease
Dal Forno et al.
Neurology 2002;58:1045-1050.
ABSTRACT | FULL TEXT  

Differential Effects of Oral Estrogen versus Oral Estrogen-Androgen Replacement Therapy on Body Composition in Postmenopausal Women
Dobs et al.
J. Clin. Endocrinol. Metab. 2002;87:1509-1516.
ABSTRACT | FULL TEXT  

Impact of Progestins on Estrogen-Induced Neuroprotection: Synergy by Progesterone and 19-Norprogesterone and Antagonism by Medroxyprogesterone Acetate
Nilsen and Brinton
Endocrinology 2002;143:205-212.
ABSTRACT | FULL TEXT  

High-dose estradiol improves cognition for women with AD: Results of a randomized study
Asthana et al.
Neurology 2001;57:605-612.
ABSTRACT | FULL TEXT  

Differential Neuroprotective Effects of Equine Estrogens Against Oxidized Low Density Lipoprotein--Induced Neuronal Cell Death
Berco and Bhavnani
Reproductive Sciences 2001;8:245-254.
ABSTRACT  

Association of Estrogen Levels With Neuropsychological Performance in Women With Schizophrenia
Hoff et al.
Am. J. Psychiatry 2001;158:1134-1139.
ABSTRACT | FULL TEXT  

Hormone Replacement Therapy and Cognition: Systematic Review and Meta-analysis
LeBlanc et al.
JAMA 2001;285:1489-1499.
ABSTRACT | FULL TEXT  

Postmenopausal Estrogen Replacement Therapy and the Risk of Alzheimer Disease
Seshadri et al.
Arch Neurol 2001;58:435-440.
ABSTRACT | FULL TEXT  

Effects of Long-Term Hormone Therapy on Cholinergic Synaptic Concentrations in Healthy Postmenopausal Women
Smith et al.
J. Clin. Endocrinol. Metab. 2001;86:679-684.
ABSTRACT | FULL TEXT  

Postmenopausal Estrogen and Estrogen-Progestin Use and 2-Year Rate of Cognitive Change in a Cohort of Older Japanese American Women: The Kame Project
Rice et al.
Arch Intern Med 2000;160:1641-1649.
ABSTRACT | FULL TEXT  

Alzheimer disease: protective factors1
Nourhashemi et al.
Am. J. Clin. Nutr. 2000;71:643s-649s.
ABSTRACT | FULL TEXT  

Lack of an Association of Estrogen Receptor {alpha} Gene Polymorphisms and Transcriptional Activity With Alzheimer Disease
Maruyama et al.
Arch Neurol 2000;57:236-240.
ABSTRACT | FULL TEXT  

Estrogen for Alzheimer's disease in women: Randomized, double-blind, placebo-controlled trial
Henderson et al.
Neurology 2000;54:295-295.
ABSTRACT | FULL TEXT  

Estrogen receptor-dependent regulation of sensory neuron survival in developing dorsal root ganglion
Patrone et al.
Proc. Natl. Acad. Sci. USA 1999;96:10905-10910.
ABSTRACT | FULL TEXT  

Short-term effects of high-dose 17{beta}-estradiol in postmenopausal PD patients: A crossover study
Blanchet et al.
Neurology 1999;53:91-91.
ABSTRACT | FULL TEXT  

Estrogen Actions in the Central Nervous System
McEwen and Alves
Endocr. Rev. 1999;20:279-307.
ABSTRACT | FULL TEXT  

A Mouse Model to Study the Effects of Hormone Replacement Therapy on Normal Mammary Gland during Menopause: Enhanced Proliferative Response to Estrogen in Late Postmenopausal Mice
Raafat et al.
Endocrinology 1999;140:2570-2580.
ABSTRACT | FULL TEXT  

Granule Cells in Aging Rats Are Sexually Dimorphic in Their Response to Estradiol
Miranda et al.
J. Neurosci. 1999;19:3316-3325.
ABSTRACT | FULL TEXT  

The Mitogen-Activated Protein Kinase Pathway Mediates Estrogen Neuroprotection after Glutamate Toxicity in Primary Cortical Neurons
Singer et al.
J. Neurosci. 1999;19:2455-2463.
ABSTRACT | FULL TEXT  

Postmenopausal estrogen replacement therapy and risk of AD: A population-based study
Waring et al.
Neurology 1999;52:965-965.
ABSTRACT | FULL TEXT  

The Neurobiology and Pharmacotherapy of Alzheimer's Disease
Felician and Sandson
J. Neuropsychiatry Clin. Neurosi. 1999;11:19-31.
ABSTRACT | FULL TEXT  

{blacksquare} REVIEW : Stress and Sex Effects on Associative Learning: For Better or for Worse
Shors
Neuroscientist 1998;4:353-364.
ABSTRACT  

The Relationships Between Age, Sex, and the Incidence of Dementia and Alzheimer Disease: A Meta-analysis
Gao et al.
Arch Gen Psychiatry 1998;55:809-815.
ABSTRACT | FULL TEXT  

Epidemiology of Dementia and Alzheimer's Disease
Hendrie
AJGP 1998;6:3S-18.
ABSTRACT | FULL TEXT  

Stress facilitates classical conditioning in males, but impairs classical conditioning in females through activational effects of ovarian hormones
Wood and Shors
Proc. Natl. Acad. Sci. USA 1998;95:4066-4071.
ABSTRACT | FULL TEXT  

Estrogen Therapy in Postmenopausal Women: Effects on Cognitive Function and Dementia
Yaffe et al.
JAMA 1998;279:688-695.
ABSTRACT | FULL TEXT  

Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer's disease
Gasparini et al.
FASEB J. 1998;12:17-34.
ABSTRACT | FULL TEXT  

Psychopathology in Women and Men: Focus on Female Hormones
Seeman
Am. J. Psychiatry 1997;154:1641-1647.
ABSTRACT | FULL TEXT  

Endocrine modulation of the neurotoxicity of gp120: Implications for AIDS-related dementia complex
Brooke et al.
Proc. Natl. Acad. Sci. USA 1997;94:9457-9462.
ABSTRACT | FULL TEXT  

Oligonucleotide Squelching Reveals the Mechanism of Estrogen Receptor Autologous Down-Regulation
Santagati et al.
Mol. Endocrinol. 1997;11:938-949.
ABSTRACT | FULL TEXT  

Estrogen for Alzheimer's Disease
JWatch Women's Health 1997;1997:21-21.
FULL TEXT  

The Neuroprotective Effects of Phytoestrogens on Amyloid beta Protein-induced Toxicity Are Mediated by Abrogating the Activation of Caspase Cascade in Rat Cortical Neurons
Wang et al.
J. Biol. Chem. 2001;276:5287-5295.
ABSTRACT | FULL TEXT